Cambrex Corporation Company Profile (NYSE:CBM)

About Cambrex Corporation (NYSE:CBM)

Cambrex Corporation logoCambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the subsidiaries, including Cambrex Charles City, Inc., Cambrex Karlskoga AB and Cambrex Profarmaco Milano S.r.l. Its products consist of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. It delivers services, such as custom organic synthesis and process development; current good manufacturing practices (cGMP) manufacturing of API and intermediates from grams to hundreds of kilograms; cGMP analytical services; controlled substance research and development (R&D) and manufacture, Schedule II-V, and contract research. It has API R&D and cGMP facilities in the United States and Europe. It supplies over 90 generic APIs.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Pharmaceuticals
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:CBM
  • CUSIP: 13201110
  • Web: www.cambrex.com
Capitalization:
  • Market Cap: $1.72 billion
  • Outstanding Shares: 32,729,000
Average Prices:
  • 50 Day Moving Avg: $53.33
  • 200 Day Moving Avg: $55.45
  • 52 Week Range: $38.30 - $62.95
P/E:
  • Trailing P/E Ratio: 19.14
  • Foreward P/E Ratio: 16.53
  • P/E Growth: 1.14
Sales & Book Value:
  • Annual Revenue: $515.45 million
  • Price / Sales: 3.34
  • Book Value: $14.38 per share
  • Price / Book: 3.65
Profitability:
  • EBITDA: $167.23 million
  • Net Margins: 17.70%
  • Return on Equity: 24.25%
  • Return on Assets: 16.45%
Debt:
  • Current Ratio: 4.15%
  • Quick Ratio: 2.37%
Misc:
  • Average Volume: 310,391 shs.
  • Beta: 2.28
  • Short Ratio: 9.07
 

Frequently Asked Questions for Cambrex Corporation (NYSE:CBM)

What is Cambrex Corporation's stock symbol?

Cambrex Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBM."

How were Cambrex Corporation's earnings last quarter?

Cambrex Corporation (NYSE:CBM) released its quarterly earnings results on Friday, August, 4th. The company reported $0.76 earnings per share for the quarter, meeting analysts' consensus estimates of $0.76. The company had revenue of $134.55 million for the quarter, compared to analyst estimates of $136.82 million. Cambrex Corporation had a net margin of 17.70% and a return on equity of 24.25%. The firm's revenue was up 13.4% on a year-over-year basis. During the same period last year, the firm earned $0.68 earnings per share. View Cambrex Corporation's Earnings History.

When will Cambrex Corporation make its next earnings announcement?

Cambrex Corporation is scheduled to release their next quarterly earnings announcement on Friday, November, 3rd 2017. View Earnings Estimates for Cambrex Corporation.

What guidance has Cambrex Corporation issued on next quarter's earnings?

Cambrex Corporation issued an update on its FY17 earnings guidance on Friday, August, 4th. The company provided earnings per share (EPS) guidance of $3.00-3.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.03. The company issued revenue guidance of $525-545 million (+7-11%), compared to the consensus revenue estimate of $536.87 million.

Where is Cambrex Corporation's stock going? Where will Cambrex Corporation's stock price be in 2017?

3 brokerages have issued twelve-month price objectives for Cambrex Corporation's stock. Their forecasts range from $61.00 to $70.00. On average, they expect Cambrex Corporation's share price to reach $65.67 in the next year. View Analyst Ratings for Cambrex Corporation.

Who are some of Cambrex Corporation's key competitors?

Who are Cambrex Corporation's key executives?

Cambrex Corporation's management team includes the folowing people:

  • Steven Mark Klosk, President, Chief Executive Officer, Director
  • Tom George Vadaketh, Chief Financial Officer, Executive Vice President
  • Shawn P. Cavanagh, Chief Operating Officer, Executive Vice President
  • Gregory P. Sargen, Executive Vice President, Corporate Development and Strategy
  • Samantha M. Hanley, Vice President, General Counsel,Corporate Secretary
  • James G. Farrell, Vice President and Corporate Controller
  • Shlomo Yanai, Non-Executive Chairman of the Board
  • Rosina B. Dixon M.D., Independent Director
  • Claes Glassell, Independent Director
  • Louis J. Grabowsky, Independent Director

Who owns Cambrex Corporation stock?

Cambrex Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include Tributary Capital Management LLC (0.71%), Eqis Capital Management Inc. (0.23%) and Beacon Financial Group (0.02%). Company insiders that own Cambrex Corporation stock include Gregory Sargen, Ilan Kaufthal, Leon J Hendrix Jr, Leon J Hendrix, Jr, Louis J Grabowsky, Peter G Tombros, Samantha Hanley, Shawn Cavanagh, Steven M Klosk and William B Korb. View Institutional Ownership Trends for Cambrex Corporation.

Who sold Cambrex Corporation stock? Who is selling Cambrex Corporation stock?

Cambrex Corporation's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc. and Beacon Financial Group. Company insiders that have sold Cambrex Corporation stock in the last year include Gregory Sargen, Leon J Hendrix Jr, Samantha Hanley, Shawn Cavanagh and Steven M Klosk. View Insider Buying and Selling for Cambrex Corporation.

Who bought Cambrex Corporation stock? Who is buying Cambrex Corporation stock?

Cambrex Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC. View Insider Buying and Selling for Cambrex Corporation.

How do I buy Cambrex Corporation stock?

Shares of Cambrex Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cambrex Corporation's stock price today?

One share of Cambrex Corporation stock can currently be purchased for approximately $52.55.


MarketBeat Community Rating for Cambrex Corporation (NYSE CBM)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  109 (Vote Outperform)
Underperform Votes:  84 (Vote Underperform)
Total Votes:  193
MarketBeat's community ratings are surveys of what our community members think about Cambrex Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cambrex Corporation (NYSE:CBM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $65.67 (24.96% upside)
Consensus Price Target History for Cambrex Corporation (NYSE:CBM)
Price Target History for Cambrex Corporation (NYSE:CBM)
Analysts' Ratings History for Cambrex Corporation (NYSE:CBM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/6/2017StephensSet Price TargetBuy$61.00N/AView Rating Details
2/6/2017Craig HallumSet Price TargetBuy$70.00N/AView Rating Details
1/17/2017First AnalysisBoost Price TargetOverweight$54.00 -> $66.00N/AView Rating Details
2/11/2016Singular ResearchLower Price TargetBuy$63.00 -> $60.00N/AView Rating Details
2/1/2016SidotiInitiated CoverageBuy$60.00N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for Cambrex Corporation (NYSE:CBM)
Earnings by Quarter for Cambrex Corporation (NYSE:CBM)
Earnings History by Quarter for Cambrex Corporation (NYSE CBM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017$0.48N/AView Earnings Details
8/4/2017Q2 2017$0.76$0.76$136.82 million$134.55 millionViewN/AView Earnings Details
5/4/2017Q1 2017$0.51$0.68$99.05 million$105.01 millionViewListenView Earnings Details
2/3/2017Q416$1.05$1.23$174.53 million$178.70 millionViewListenView Earnings Details
11/4/2016Q3$0.41$0.47$96.07 million$99.90 millionViewListenView Earnings Details
7/28/2016Q216$0.59$0.68$114.85 million$118.22 millionViewListenView Earnings Details
4/29/2016Q116$0.34$0.50$83.61 million$94.74 millionViewListenView Earnings Details
2/9/2016Q4$0.83$0.53$152.94 million$156.90 millionViewListenView Earnings Details
11/3/2015Q3$0.38$0.40$101.09 million$92.97 millionViewListenView Earnings Details
7/30/2015Q215$0.44$0.63$110.03 million$106.40 millionViewListenView Earnings Details
5/1/2015Q115$0.23$0.29$76.01 million$78.20 millionViewListenView Earnings Details
2/6/2015Q414$0.50$0.60$117.90 million$128.80 millionViewListenView Earnings Details
10/30/2014Q314$0.29$0.28$94.25 million$81.10 millionViewListenView Earnings Details
8/12/2014$0.21$0.32ViewN/AView Earnings Details
8/1/2014Q214$0.28$0.32$92.70 million$98.00 millionViewListenView Earnings Details
5/2/2014Q114$0.23$0.05$79.40 million$66.20 millionViewListenView Earnings Details
2/11/2014Q4$0.30$0.30$95.25 million$103.00 millionViewListenView Earnings Details
11/1/2013Q313$0.21$0.20$83.60 million$78.00 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.26$0.10$73.70 million$61.60 millionViewListenView Earnings Details
5/3/2013Q1 2013$0.22$0.36$76.15 million$74.58 millionViewListenView Earnings Details
2/6/2013Q4 2012$0.13$0.26$68.30 million$69.93 millionViewListenView Earnings Details
11/5/2012Q312$0.12$0.07$61.00 million$59.21 millionViewN/AView Earnings Details
8/1/2012$0.21$0.33ViewN/AView Earnings Details
5/3/2012$0.14$0.24ViewN/AView Earnings Details
2/6/2012$0.12$0.10ViewN/AView Earnings Details
11/3/2011$0.07$0.10ViewN/AView Earnings Details
8/2/2011$0.13$0.16ViewN/AView Earnings Details
5/5/2011$0.08$0.10ViewN/AView Earnings Details
2/10/2011$0.10$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cambrex Corporation (NYSE:CBM)
2017 EPS Consensus Estimate: $2.91
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.48$0.51$0.50
Q2 20172$0.71$0.74$0.73
Q3 20172$0.48$0.52$0.50
Q4 20172$1.18$1.20$1.19
Q1 20181$0.63$0.63$0.63
Q2 20181$0.87$0.87$0.87
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cambrex Corporation (NYSE:CBM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Cambrex Corporation (NYSE:CBM)
Insider Ownership Percentage: 2.48%
Insider Trades by Quarter for Cambrex Corporation (NYSE:CBM)
Institutional Ownership by Quarter for Cambrex Corporation (NYSE:CBM)
Insider Trades by Quarter for Cambrex Corporation (NYSE:CBM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/2/2017Steven M KloskCEOSell4,000$54.96$219,840.00View SEC Filing  
9/1/2017Steven M KloskCEOSell12,000$51.53$618,360.00View SEC Filing  
8/1/2017Steven M KloskCEOSell12,000$61.39$736,680.00View SEC Filing  
7/3/2017Steven M KloskCEOSell12,000$59.66$715,920.00View SEC Filing  
6/12/2017Samantha HanleyVPSell14,000$57.56$805,840.00View SEC Filing  
6/6/2017Leon J Hendrix JrDirectorSell20,656$55.95$1,155,703.20View SEC Filing  
6/1/2017Steven M KloskCEOSell12,000$54.19$650,280.00View SEC Filing  
5/1/2017Steven M KloskCEOSell12,000$58.20$698,400.00View SEC Filing  
4/3/2017Steven M KloskCEOSell12,000$54.58$654,960.00View SEC Filing  
3/1/2017Steven M KloskCEOSell12,000$56.70$680,400.00View SEC Filing  
2/27/2017Shawn CavanaghCOOSell19,620$55.95$1,097,739.00View SEC Filing  
2/16/2017Steven M KloskCEOSell23,822$52.50$1,250,655.00View SEC Filing  
2/13/2017Steven M KloskCEOSell63,178$52.55$3,320,003.90View SEC Filing  
2/7/2017Gregory SargenEVPSell30,000$54.88$1,646,400.00View SEC Filing  
2/7/2017Shawn CavanaghCOOSell20,380$55.12$1,123,345.60View SEC Filing  
12/14/2016Shawn CavanaghCOOSell30,000$53.58$1,607,400.00View SEC Filing  
11/11/2016Gregory SargenInsiderSell22,500$52.02$1,170,450.00View SEC Filing  
7/11/2016William B KorbDirectorSell3,420$55.00$188,100.00View SEC Filing  
6/8/2016William B KorbDirectorSell4,142$52.47$217,330.74View SEC Filing  
6/1/2016William B KorbDirectorSell8,000$51.06$408,480.00View SEC Filing  
5/9/2016Steven M KloskCEOSell14,005$49.00$686,245.00View SEC Filing  
5/5/2016Steven M KloskCEOSell16,430$49.13$807,205.90View SEC Filing  
5/3/2016William B KorbDirectorSell8,000$49.09$392,720.00View SEC Filing  
3/16/2016Steven M KloskCEOSell19,565$41.00$802,165.00View SEC Filing  
3/15/2016Louis J GrabowskyDirectorBuy750$40.10$30,075.00View SEC Filing  
3/10/2016William B KorbDirectorSell8,000$41.38$331,040.00View SEC Filing  
2/11/2016Gregory SargenCFOSell13,622$36.16$492,571.52View SEC Filing  
2/11/2016Shawn CavanaghCOOSell18,342$36.13$662,696.46View SEC Filing  
2/11/2016Steven M. KloskCEOSell39,542$36.20$1,431,420.40View SEC Filing  
12/15/2015Leon J. Hendrix, Jr.DirectorSell7,000$51.34$359,380.00View SEC Filing  
12/11/2015Peter G. TombrosDirectorSell31,236$51.37$1,604,593.32View SEC Filing  
11/30/2015Ilan KaufthalDirectorSell52,315$54.32$2,841,750.80View SEC Filing  
11/13/2015Gregory SargenCFOSell28,750$49.14$1,412,775.00View SEC Filing  
11/6/2015Samantha HanleyVPSell15,000$52.03$780,450.00View SEC Filing  
8/27/2015William B. KorbDirectorSell3,600$48.00$172,800.00View SEC Filing  
5/21/2015Ilan KaufthalDirectorSell50,000$41.31$2,065,500.00View SEC Filing  
5/11/2015Gregory SargenCFOSell25,000$38.44$961,000.00View SEC Filing  
2/12/2015Aldo MagniniDirectorSell7,500$32.75$245,625.00View SEC Filing  
2/12/2015Gregory SargenCFOSell25,000$32.64$816,000.00View SEC Filing  
2/10/2015Steven M KloskCEOSell45,000$30.32$1,364,400.00View SEC Filing  
9/11/2014Shawn CavanaghCOOSell56,251$22.56$1,269,022.56View SEC Filing  
9/3/2014Steven M KloskCEOSell126,257$22.01$2,778,916.57View SEC Filing  
9/2/2014William M HaskelSVPSell9,400$21.94$206,236.00View SEC Filing  
8/19/2014Steven M KloskCEOSell4,702$22.00$103,444.00View SEC Filing  
8/7/2014Steven M KloskCEOSell1,200$22.52$27,024.00View SEC Filing  
8/7/2014William M HaskelSVPSell28,100$22.50$632,250.00View SEC Filing  
8/5/2014Gregory SargenCFOSell50,000$22.34$1,117,000.00View SEC Filing  
2/28/2014Leon Hendrix, Jr.DirectorSell23,000$20.09$462,070.00View SEC Filing  
2/20/2014Aldo MagniniDirectorSell6,000$22.10$132,600.00View SEC Filing  
12/5/2013Paolo RussoloInsiderSell35,000$18.40$644,000.00View SEC Filing  
11/11/2013Gregory SargenCFOSell20,000$18.92$378,400.00View SEC Filing  
11/11/2013John MillerDirectorSell2,000$19.21$38,420.00View SEC Filing  
5/24/2013Paolo RussoloInsiderSell32,903$12.53$412,274.59View SEC Filing  
5/16/2013Leon J Hendrix JrDirectorSell1,120$13.40$15,008.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Cambrex Corporation (NYSE:CBM)
Latest Headlines for Cambrex Corporation (NYSE:CBM)
Source:
Loading headlines, please wait.

Social

Chart

Cambrex Corporation (CBM) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.